Overall, our study not only establishes a causal relationship between AD‐associated CA2 PNN disruption with the loss of social memory but also provides compelling evidence that pharmacological inhibition of PNN proteolysis can prevent social memory loss, suggesting PNNs as a potential therapeutic target. Here, CA2 is linked to Alzheimer disease.